Lipid-Lowering Therapy after Acute Coronary Syndrome

Lipid-Lowering Therapy after Acute Coronary Syndrome

Achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets remains a significant challenge in clinical practice. This review assesses the barriers to reaching LDL-C goals and explores the potential solutions to these issues. When aiming for the recommended LDL-C goal, strate...

Full description

Bibliographic Details
Main Authors: Edita Pogran, Achim Leo Burger, David Zweiker, Christoph Clemens Kaufmann, Marie Muthspiel, Gersina Rega-Kaun, Alfa Wenkstetten-Holub, Johann Wojta, Heinz Drexel, Kurt Huber
Format: Article
Language:English
Published: MDPI AG 2024-04-01
Series:Journal of Clinical Medicine
Subjects:
lipid-lowering therapy
acute coronary syndrome
cardiovascular disease
secondary prevention
statins
ezetimibe
Online Access:https://www.mdpi.com/2077-0383/13/7/2043

Internet

https://www.mdpi.com/2077-0383/13/7/2043

Similar Items